Stocks · Health care · Pharmaceutical Preparations

BIOMARIN PHARMACEUTICAL INC

BMRN Clue Score68
United States Fiscal year ends December CIK 0001048477 Results filed 2 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Erin Burkhart
20 May 2025
GVP, Chief Accounting Officer
Sold on a plan
1,786
$59.31
$105.93K
Cristin Hubbard
2 May 2025
EVP, Chief Commercial Officer
Sold on a plan
273
$64.92
$17.72K
Erin Burkhart
19 Mar 2025
GVP, Chief Accounting Officer
Sold on a plan
1,295
$71.52
$92.62K
Erin Burkhart
24 Feb 2025
GVP, Chief Accounting Officer
Sold on a plan
1,344
$68.38
$91.90K
Erin Burkhart
13 Aug 2024
GVP, Chief Accounting Officer
Sold on a plan
714
$90.00
$64.26K
Jeffrey Robert Ajer
2 May 2024
EVP, Chief Commercial Officer
Sold on a plan
5,000
$82.91
$414.55K
Erin Burkhart
10 Apr 2024
GVP, Chief Accounting Officer
Sold on a plan
2,286
$90.00
$205.74K
George Eric Davis
28 Mar 2024
EVP, Chief Legal Officer
Sold on a plan
24,602
$88.34
$2.17M
Jeffrey Robert Ajer
5 Mar 2024
EVP, Chief Commercial Officer
Sold on a plan
4,000
$87.07
$348.28K
George Eric Davis
13 Dec 2023
EVP, Chief Legal Officer
Sold on a plan
13,764
$95.30
$1.31M
Jeffrey Robert Ajer
16 Aug 2023
EVP, Chief Commercial Officer
Sold on a plan
5,000
$90.00
$450.00K
Showing 250 of 413 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 620
Amendments (4/A) skipped 18
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 11
Sales straight out of an exercise 237
Sales at will 122
Transactions with no price 0
Shares from compensation/vesting 6,827,559
Sales filed before the plan box existed 106
History held since 2 Nov 2006